In the last trading session, 49.56 million shares of the Portage Biotech Inc (NASDAQ:PRTG) were traded, and its beta was 98.43. Most recently the company’s share price was $6.00, and it changed around $3.3 or 122.20% from the last close, which brings the market valuation of the company to $79.98M. PRTG currently trades at a discount to its 52-week high of $61.99, offering almost -933.17% off that amount. The share price’s 52-week low was $2.10, which indicates that the current value has risen by an impressive 65.0% since then. We note from Portage Biotech Inc’s average daily trading volume that its 10-day average is 5.33 million shares, with the 3-month average coming to 102.78K.
Portage Biotech Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended PRTG as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Portage Biotech Inc is expected to report earnings per share of 0 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Portage Biotech Inc (NASDAQ:PRTG) trade information
Instantly PRTG has showed a green trend with a performance of 122.20% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 8.28 on recent trading dayincreased the stock’s daily price by 27.54%. The company’s shares are currently down -83.52% year-to-date, but still up 118.18% over the last five days. On the other hand, Portage Biotech Inc (NASDAQ:PRTG) is 52.75% up in the 30-day period. We can see from the shorts that 3029.0 shares have been sold at a short interest cover period of 0.04 day(s).
The consensus price target as assigned by Wall Street analysts is $19.5, which translates to bulls needing to increase their stock price by 69.23% from its current value. Analyst projections state that PRTG is forecast to be at a low of $18 and a high of $21.
Portage Biotech Inc (PRTG) estimates and forecasts
Portage Biotech Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -48.66 percent over the past six months and at a -271.05% annual growth rate that is well below the industry average of 18.30%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -48.08%.
PRTG Dividends
Portage Biotech Inc’s next quarterly earnings report is expected to be released in September.
Portage Biotech Inc (NASDAQ:PRTG)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 36.40% of Portage Biotech Inc shares, and 50.97% of them are in the hands of institutional investors. The stock currently has a share float of 80.14%. Portage Biotech Inc stock is held by 26.0 institutions, with ARMISTICE CAPITAL, LLC being the largest institutional investor. By 2024-06-30, it held 7.1866% of the shares, which is about 1.5 million shares worth $0.32 million.
BISON WEALTH, LLC, with 1.0212% or 0.21 million shares worth $0.12 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
